TY - JOUR AU - Kavanaugh, A. AU - Mease, P. J. AU - Gomez-Reino, J. J. AU - Adebajo, A. O. AU - Wollenhaupt, J. AU - Gladman, D. D. PY - 2014 DA - 2014// TI - Treatment of psoriatic arthritis in a phase 3 randomized, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-205056 DO - 10.1136/annrheumdis-2013-205056 ID - Kavanaugh2014 ER - TY - JOUR AU - Cutolo, M. AU - Myerson, G. E. AU - Fleischmann, R. AU - Liote, F. AU - Diaz-Gonzalez, F. AU - Bosch, F. PY - 2016 DA - 2016// TI - A phase III, randomized, controlled trial of apremilast in patients with psoriatic arthritis: results of the PALACE 2 trial JO - J Rheumatol VL - 43 UR - https://doi.org/10.3899/jrheum.151376 DO - 10.3899/jrheum.151376 ID - Cutolo2016 ER - TY - JOUR AU - Edwards, C. J. AU - Blanco, F. J. AU - Crowley, J. AU - Birbara, C. A. AU - Jaworski, J. AU - Aelion, J. PY - 2016 DA - 2016// TI - Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3) JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-207963 DO - 10.1136/annrheumdis-2015-207963 ID - Edwards2016 ER - TY - JOUR AU - Taylor, W. AU - Gladman, D. AU - Helliwell, P. AU - Marchesoni, A. AU - Mease, P. AU - Mielants, H. PY - 2006 DA - 2006// TI - Classification criteria for psoriatic arthritis: development of new criteria from a large international study JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21972 DO - 10.1002/art.21972 ID - Taylor2006 ER - TY - JOUR AU - Felson, D. T. AU - Anderson, J. J. AU - Boers, M. AU - Bombardier, C. AU - Furst, D. AU - Goldsmith, C. PY - 1995 DA - 1995// TI - American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis JO - Arthritis Rheum VL - 38 UR - https://doi.org/10.1002/art.1780380602 DO - 10.1002/art.1780380602 ID - Felson1995 ER - TY - JOUR AU - Miedany, Y. PY - 2005 DA - 2005// TI - Recent developments in management of psoriatic arthritis JO - Curr Rheumatol Rev VL - 1 UR - https://doi.org/10.2174/1573397052954154 DO - 10.2174/1573397052954154 ID - Miedany2005 ER - TY - JOUR AU - Heuft-Dorenbosch, L. AU - Spoorenberg, A. AU - Tubergen, A. AU - Landewe, R. AU - Tempel, H. AU - Mielants, H. PY - 2003 DA - 2003// TI - Assessment of enthesitis in ankylosing spondylitis JO - Ann Rheum Dis VL - 62 UR - https://doi.org/10.1136/ard.62.2.127 DO - 10.1136/ard.62.2.127 ID - Heuft-Dorenbosch2003 ER - TY - JOUR AU - Mease, P. J. AU - Woolley, J. M. AU - Bitman, B. AU - Wang, B. C. AU - Globe, D. R. AU - Singh, A. PY - 2011 DA - 2011// TI - Minimally important difference of health assessment questionnaire in psoriatic arthritis: relating thresholds of improvement in functional ability to patient-rated importance and satisfaction JO - J Rheumatol VL - 38 UR - https://doi.org/10.3899/jrheum.110546 DO - 10.3899/jrheum.110546 ID - Mease2011 ER - TY - JOUR AU - Fries, J. F. AU - Spitz, P. W. AU - Young, D. Y. PY - 1982 DA - 1982// TI - The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales JO - J Rheumatol VL - 9 ID - Fries1982 ER - TY - JOUR AU - Mease, P. AU - Gladman, D. AU - Kavanaugh, A. AU - Nakasato, P. AU - Guerette, B. AU - Teng, L. PY - 2018 DA - 2018// TI - Characterization of clinical benefits in subjects classified as ACR20 non-responders at week 104 of apremilast treatment: subanalysis of 3 long-term, phase III trials [abstract OP0309] JO - Ann Rheum Dis VL - 77 ID - Mease2018 ER - TY - JOUR AU - Mease, P. J. AU - Gladman, D. D. AU - Kavanaugh, A. AU - Nakasato, P. AU - Guerette, B. AU - Teng, L. PY - 2017 DA - 2017// TI - Characterization of clinical benefits in subjects classified as ACR20 non-responders at week 104 of apremilast treatment: subanalysis of 3 long-term, phase III trials [abstract] JO - Arthritis Rheumatol VL - 69 ID - Mease2017 ER - TY - JOUR AU - Gladman, D. D. AU - Farewell, V. T. AU - Nadeau, C. PY - 1995 DA - 1995// TI - Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model JO - J Rheumatol VL - 22 ID - Gladman1995 ER -